Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 26,949 shares at $35.16 ($948K) on 2024-10-18, disclosed to the SEC on 2024-10-22.
Scheduled sale ($948k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.16 | 13,414 | $472K | 49.8% |
| 2 | $35.16 | 13,414 | $472K | 49.8% |
| 3 | $35.06 | 121 | $4K | 0.4% |
| Total | $35.16 avg | 26,949 | $948K | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |